Etude de validation du "Michigan alcoholism screening test" (MAST) en langue française

Le but de cette étude est de répondre aux 3 questions suivantes: - 1) Le test de MAST est-il applicable, dans sa traduction française, à la population d'un service de médecine interne d'un hôpital universitaire en Suisse romande ? - 2) Le test de MAST apporte-t-il des résultats concordants avec le diagnostic clinique d'une part, et avec les résultats tirés de la littérature d'autre part ? - 3) De quelles façons peut-on définir et choisir deux valeurs critiques du test afin d'optimaliser l'utilisation du test de MAST dans l'étude comparative projetée ? ANNEXE: Traduction littérale en langue française du : "Michigan Alcoholism Screening Test" (MAST); etc.

Governor’s Office of Drug Control Policy Performance Plan, FY2014

Agency Performance Plan, Governor’s Office of Drug Control Policy

Common variants near MC4R are associated with fat mass, weight and risk of obesity.

To identify common variants influencing body mass index (BMI), we analyzed genome-wide association data from 16,876 individuals of European descent. After previously reported variants in FTO, the strongest association signal (rs17782313, P = 2.9 x 10(-6)) mapped 188 kb downstream of MC4R (melanocortin-4 receptor), mutations of which are the leading cause of monogenic severe childhood-onset obesity. We confirmed the BMI association in 60,352 adults (per-allele effect = 0.05 Z-score units; P = 2.8 x 10(-15)) and 5,988 children aged 7-11 (0.13 Z-score units; P = 1.5 x 10(-8)). In case-control analyses (n = 10,583), the odds for severe childhood obesity reached 1.30 (P = 8.0 x 10(-11)). Furthermore, we observed overtransmission of the risk allele to obese offspring in 660 families (P (pedigree disequilibrium test average; PDT-avg) = 2.4 x 10(-4)). The SNP location and patterns of phenotypic associations are consistent with effects mediated through altered MC4R function. Our findings establish that common variants near MC4R influence fat mass, weight and obesity risk at the population level and reinforce the need for large-scale data integration to identify variants influencing continuous biomedical traits.

Governor’s Office of Drug Control Policy Performance Plan, FY 2014

The Agency Performance Report for the Governor’s Office of Drug Control Policy is published in accordance with the Accountable Government Act. The information provided illustrates accountability to stakeholders and citizens. The report is indicative of the agency’s progress in achieving goals consistent with the enterprise strategic plan, the agency strategic plan and agency performance plan.

Governor’s Office of Drug Control Policy Performance Plan, FY2015

Agency Performance Plan, Governor’s Office of Drug Control Policy

Report on the Governor’s Office of Drug Control Policy for the year ended June 30, 2014

Report on the Governor’s Office of Drug Control Policy for the year ended June 30, 2014

Letter health consultation : Mason City coal gasification plant site, Mason City, Iowa EPA facility ID: IAD980969190 (2008)

This letter has been prepared as a consultation to EPA regarding the first five-year review of the Mason City Coal Gasification Plant Site, located in Mason City, Iowa to provide an evaluation of the public health status of the site.

Letter health consultation : Northwest States Portland Cement Company site, site, Mason City, Iowa EPA facility ID: IAD98053431 (2008)

This letter has been prepared as a consultation to EPA regarding the third five year review of the Northwestern States Portland Cement Company Site, located North of Mason City, Iowa in Cerro Gordo County to provide an evaluation of the public health status of the site.